Literature DB >> 22847535

Hormone receptor status affects locoregional control in HER2-positive breast cancer treated with trastuzumab.

Mary Kay Barton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847535     DOI： 10.3322/caac.21152

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  2 in total

1.  Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.

Authors:  Saranya Chumsri; Daniel J Serie; Zhuo Li; Katherine L Pogue-Geile; Aixa E Soyano-Muller; Afshin Mashadi-Hossein; Sarah Warren; Yanyan Lou; Gerardo Colon-Otero; Keith L Knutson; Edith A Perez; Alvaro Moreno-Aspitia; E Aubrey Thompson
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

2.  The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.

Authors:  K Chen; J Quan; J Yang; Z Chen
Journal:  Clin Transl Oncol       Date:  2019-06-17       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.